Abstract: Esophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer with poor prognosis. Accurate prognostic models are essential for guiding personalized treatment strategies. However, ...
Abstract: Multiple open-circuit (OC) faults have severely deteriorated the reliable operation of active neutral-point-clamped (ANPC) inverters. To achieve fast and accurate detection for multiple OC ...
Alterity Therapeutics enters 2026 with growing confidence following the completion of a Phase II clinical program for lead asset ATH434 in neurodegenerative disease, Multiple System Atrophy (MSA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results